First participant dosed in Terns’ trial of TERN-601 oral GLP-1ra for treatment of obesityTerns Pharmaceuticals has announced that the first participant has been dosed in the Phase 1 clinical trial of TERN-601, the company’s...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment2 days ago